DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/j9xzkk/investigation) has appear the accession of the “Investigation Address on China’s Atorvastatin Market, 2010-2019” address to their offering.
With the change of lifestyles brought about by the bread-and-er development and the ascent incomes, the cardinal of hyperlipidemia patients in China keeps growing, actuality estimated to ability 160-200 actor in the a future.
Atorvastatin, a accepted biologic that can lower claret cholesterol levels, was developed by Pfizer beneath the barter name of Lipitor. Boasting about 20 years of use in over 100 countries in the absolute world, atorvastation has accepted its ability and assurance in hundreds of analytic tests and hundreds of millions of analytic medications. Large amounts of affirmation and analytic practices accept accepted that atorvastation (10-80 mg) has able furnishings in abbreviation low-density lipoprotein cholesterol (LDL-C). For patients with coronary affection disease, ischemic stroke, diabetes and hypertension, atorvastation is accepted to abate the cardinal of cases of above cardiovascular diseases safely. By the end of 2014, the sales amount of atorvastation has surpassed USD 100 billion about the world, creating a aces phenomenon amid all the medicines for sale.
After entering China, atorvastatin develops fast with anniversary sales amount ascent from beneath than CNY 70 actor in 2005 to CNY 1.374 billion in 2014 and CAGR extensive up to 41% during 2005-2014. Atorvastatin enjoys a all-inclusive appeal in China. And such companies as Pfizer Inc (Ireland), Pfizer Inc (the US), Topfond and Beijing Jialin Pharmaceutical Co., Ltd absorb the market, amid which Pfizer (the US) has the better bazaar allotment of about 65% in 2014 with sales amount extensive up to CNY 895 million.
Key Topics Covered:
1 Related Concepts of Atorvastatin
2 Bazaar Profile of Atorvastatin in China
3 Survey on Sales Status of Atorvastatin in China, 2010-2014
4 Survey on Bazaar Allotment of Above Manufacturers of Atorvastatin in China, 2010-2014
5 Survey on Dosage Forms of Atorvastatin in China, 2010-2014
6 Reference Price of Atorvastatin in Chinese Hospitals in 2014
7 Above Manufacturers of Atorvastatin in Chinese Market, 2010-2014
8 Bazaar Outlook of Atorvastatin in China, 2015-2019
– Ebang Pharmaceutical
– Pfizer Inc
– Beijing Jialin Pharmaceutical Co., Ltd
For added advice appointment http://www.researchandmarkets.com/research/j9xzkk/investigation
All You Need To Know About Atorvastatin Dosage Forms | Atorvastatin Dosage Forms – atorvastatin dosage forms
| Allowed for you to my blog site, with this occasion I’m going to explain to you about atorvastatin dosage forms